2. Search Result
Search Result
Results for "

Lysophospholipids

" in MedChemExpress (MCE) Product Catalog:

45

Inhibitors & Agonists

1

Fluorescent Dyes

2

Biochemical Assay Reagents

1

Peptides

3

Natural
Products

10

Isotope-Labeled Compounds

14

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N9410
    Lysophosphatidylcholine 18:2

    1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC; LPC(18:2/0:0); LysoPC(18:2)

    		 Endogenous Metabolite Metabolic Disease
    Lysophosphatidylcholine 18:2 (1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC), a lysophospholipid, is a potential biomarker identified from insulin resistance (IR) polycystic ovary syndrome (PCOS). Low plasma Lysophosphatidylcholine 18:2 also has been shown to predict impaired glucose tolerance, insulin resistance, type 2 diabetes, coronary artery disease, and memory impairment .
    Lysophosphatidylcholine 18:2
  • HY-103660
    18:0 LYSO-PE

    		Liposome Neurological Disease
    18:0 LYSO-PE is a lysophospholipid that can induce [Ca 2+]i increase.
    18:0 LYSO-PE
  • HY-113123
    LysoPC(14:0/0:0)

    14:0 Lyso PC; 1-myristoyl-sn-glycero-3-phosphatidylcholine

    		 Endogenous Metabolite Neurological Disease Metabolic Disease
    LysoPC(14:0/0:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. LysoPC(14:0/0:0) has potent antispasmodic effect .
    LysoPC(14:0/0:0)
  • HY-113010
    1-Arachidoyl-sn-glycero-3-phosphocholine

    		Endogenous Metabolite Others
    1-Arachidoyl-sn-glycero-3-phosphocholine is a lysophospholipid (LyP).
    1-Arachidoyl-sn-glycero-3-phosphocholine
  • HY-W140439
    1-Oleoyl-sn-glycero-3-phosphocholine

    18:1 Lyso PC

    		 Endogenous Metabolite Inflammation/Immunology
    1-Oleoyl-sn-glycero-3-phosphocholine (18:1 Lyso PC), a lysophospholipid, is a GPR82 inhibitor. 1-Oleoyl-sn-glycero-3-phosphocholine abrogates constitutive Gi-coupled GPR82 activity, shifts active/inactive equilibrium to inactive, suppresses Gi protein activation, increases cAMP production, and decreases GTPγS binding to Gαi proteins. 1-Oleoyl-sn-glycero-3-phosphocholine contributes to adipocyte lipolysis regulation.1-Oleoyl-sn-glycero-3-phosphocholine exhibits reduced serum levels in mouse models of steatohepatitis, linked to hepatic Lpcat 1-4 up-regulation .
    1-Oleoyl-sn-glycero-3-phosphocholine
  • HY-W355700
    1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine

    		Drug Metabolite Infection
    1-oleoyl-sn-glycero-3-phosphoethanolamine (LysoPE 18:1) is a lysophosphatidylethanolamine molecule involved in phospholipid metabolism, targeting cell membrane receptors (such as G protein-coupled receptors) to regulate cell signaling pathways. 1-oleoyl-sn-glycero-3-phosphoethanolamine may activate mitogen-activated protein kinase (MAPK) signaling, promote cell migration, regulate inflammatory responses and lipid metabolism, and has both pro-inflammatory and anti-inflammatory activities. 1-oleoyl-sn-glycero-3-phosphoethanolamine is mainly used in the screening of biomarkers for metabolic diseases (such as non-alcoholic fatty liver disease and obesity), as well as the study of the mechanism of lysophospholipids in cell membrane homeostasis and signal transduction .
    1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine
  • HY-W020035
    L-α-lysophosphatidylinositol (Soy) sodium

    		GPR55 Neurological Disease
    L-α-lysophosphatidylinositol Soy sodium is an endogenous ligand of GPR55. L-α-lysophosphatidylinositol Soy sodium is an endogenous lysophospholipid and endocannabinoid neurotransmitter that belongs to the class of lysophospholipids .
    L-α-lysophosphatidylinositol (Soy) sodium
  • HY-126213
    1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine sodium

    18:1 Lyso-PS

    		 NADPH Oxidase Interleukin Related Apoptosis Inflammation/Immunology
    Oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine sodium (18:1 Lyso-PS) is a modified PS product generated following NADPH oxidase activation and Lyso-PS signal transduction. 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine sodium signals through macrophage G2A to enhance the phagocytic uptake of PS-dependent apoptotic (apoptosis) neutrophils and PS-exposed activated neutrophils. 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine sodium enhances macrophage phagocytic uptake of apoptotic cells, carboxylate-modified microspheres, and PS-exposed non-apoptotic activated neutrophils. 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine sodium serves as an acyl acceptor substrate for the lysophosphatidyltransferase At1g78690p to generate diacylphosphatidylserine. 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine sodium reduces the secretion of IL-8 and decreases the proportion of viable colon cancer cells. 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine sodium is applicable to studies on peritonitis and inflammatory bowel disease .
    1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine sodium
  • HY-107572
    PD 128042

    CI 976

    		 Acyltransferase Metabolic Disease
    PD 128042 (CI 976) is a potent, orally active, and selective inhibitor of ACAT (acyl coenzyme A:cholesterol acyltransferase) with an IC50s of 73 nM. PD 128042 is also a potent LPAT (lysophospholipid acyltransferase) inhibitor. PD 128042 inhibits Golgi-associated LPAT activity (IC50=15 μM). PD 128042 inhibits multiple membrane trafficking steps, including ones found in the endocytic and secretory pathway .
    PD 128042
  • HY-141617
    1-Palmitoyl-2-hydroxy-sn-glycero-3-PE

    		Liposome Metabolic Disease
    1-Palmitoyl-2-hydroxy-sn-glycero-3-PE is a naturally occurring lysophospholipid. 1-Palmitoyl-2-hydroxy-sn-glycero-3-PE also acts as an immune response regulator and toxicity alleviator produced by Microcystis aeruginosa under Cu 2+ stress .
    1-Palmitoyl-2-hydroxy-sn-glycero-3-PE
  • HY-138622
    24:0 Lyso PC

    		Liposome Others
    24:0 Lyso PC is a lysophospholipid (LyP). 24:0 Lyso PC could be used for mRNA drug delivery .
    24:0 Lyso PC
  • HY-156041
    Lysophosphatidylethanolamines, egg

    Lyso-PE (egg); LPE (egg); L-α-lysophosphatidylethanolamine

    		 Endogenous Metabolite Metabolic Disease
    Lysophosphatidylethanolamine (LPE) is a naturally-occurring lysophospholipid that can be generated via deacylation of phosphatidylethanolamine by phospholipase A2 (PLA2). It increases the phosphorylation of ERK1/2 in PC12 cells, an effect that can be blocked by the MEK inhibitors U-0126 (HY-12031A) and PD 98059 (HY-12028) and the EGFR inhibitor AG-1478 (HY-13524).1 LPE also increases neurite outgrowth and expression of neurofilament M in PC12 cells. LPE inhibits the activity of phospholipase D (PLD) partially purified from cabbage.3 This product contains lysophosphatidylethanolamine molecular species with variable fatty acyl chain lengths at the sn-1 position and a hydroxy group at the sn-2 position.
    Lysophosphatidylethanolamines, egg
  • HY-164238
    LysoPC(18:3)

    		Endogenous Metabolite Cancer
    LysoPC(18:3) is a lysophospholipid (LyP). LysoPC(18:3) can be used as a lipid biomarker in the diagnosis of breast cancer .
    LysoPC(18:3)
  • HY-W704966
    2-Stearoyl-sn-glycero-3-phosphocholine

    		Endogenous Metabolite Metabolic Disease
    2-Stearoyl-sn-glycero-3-PC is a lysophospholipid that contains stearic acid (HY-B2219) at the sn-2 position. It has been found in rabbit myocardium.
    2-Stearoyl-sn-glycero-3-phosphocholine
  • HY-157623
    16:0 Lyso PS

    1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-L-serine sodium

    		 Biochemical Assay Reagents Others
    16:0 Lyso PS (1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-L-serine sodium) is a lysophospholipid. 16:0 Lyso PS serves as a standard for preparing standard curves .
    16:0 Lyso PS
  • HY-W339838
    1-Myristoyl-2-hydroxy-sn-glycero-3-PG sodium

    14:0 Lyso PG

    		 Liposome Cancer
    1-Myristoyl-2-hydroxy-sn-glycero-3-PG sodium is a lysophospholipid containing myristic acid (14:0) at the sn-1 position. It has been used in the generation of micelles, liposomes, and other types of artificial membranes, including lipid-based drug carrier systems.
    1-Myristoyl-2-hydroxy-sn-glycero-3-PG sodium
  • HY-145505
    1-Oleoyl-2-hydroxy-sn-glycero-3-PG sodium

    18:1 Lyso-PG; 1-Oleoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol); 1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoglycerol

    		 Endogenous Metabolite Liposome Metabolic Disease
    1-Oleoyl-2-hydroxy-sn-glycero-3-PG (18:1 Lyso PE) sodium is a lysophospholipid containing oleic acid (18:1) at the sn-1 position. It can be used in the generation of micelles, liposomes, and other types of artificial membranes, including lipid-based drug carrier systems.
    1-Oleoyl-2-hydroxy-sn-glycero-3-PG sodium
  • HY-145507
    1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) sodium

    1-Palmitoyl-2-hydroxy-sn-glycero-3-PG sodium; 16:0 Lyso PG; PG(16:0/0:0); 1-Hexadecanoyl-sn-glycero-3-phospho-(1'racglycerol) sodium

    		 Liposome Metabolic Disease
    1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (16:0 Lyso PE) sodium is a lysophospholipid containing palmitic acid (16:0) at the sn-1 position. It can be used in the generation of micelles, liposomes, and other types of artificial membranes, including lipid-based drug carrier systems.
    1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) sodium
  • HY-12812
    Autotaxin modulator 1

    		Phosphodiesterase (PDE) Neurological Disease Cancer
    Autotaxin modulator 1 is an autotaxin (ATX) enzyme inhibitor, extracted from patent WO 2014018881 A1, Compound Example 12b. Autotaxin modulator 1 is expected to be useful for researching demyelination due to injury or disease, as well as for researching proliferative disorders such as cancer .
    Autotaxin modulator 1
  • HY-N9410S
    Lysophosphatidylcholine 18:2-d9

    1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC-d9

    		 Isotope-Labeled Compounds Endogenous Metabolite Metabolic Disease
    Lysophosphatidylcholine 18:2-d9 is deuterium labeled Lysophosphatidylcholine 18:2. Lysophosphatidylcholine 18:2 (1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC), a lysophospholipid, is a potential biomarker identified from insulin resistance (IR) polycystic ovary
    Lysophosphatidylcholine 18:2-d9
  • HY-113123S1
    LysoPC(14:0/0:0)-d7

    14:0 Lyso PC-d7; 1-myristoyl-sn-glycero-3-phosphatidylcholine-d7

    		 Isotope-Labeled Compounds Endogenous Metabolite Neurological Disease Metabolic Disease
    LysoPC(14:0/0:0)-d7 (14:0 Lyso PC-d7) is deuterium labeled LysoPC(14:0/0:0). LysoPC(14:0/0:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. LysoPC(14:0/0:0) has potent antispasmodic effect .
    LysoPC(14:0/0:0)-d7
  • HY-P10053
    sPLA2-IIA Inhibitor

    		Phospholipase Metabolic Disease
    sPLA2-IIA Inhibitor is a cyclic pentapeptide analog of FLSYK (cyclic 2-Nal-Leu-Ser-2-Nal-Arg (c2)), that binds to hGIIA (human IIA phospholipase A2) and inhibits its hydrolytic ability. sPLA2 is a member of the esterase superfamily that catalyzes the hydrolysis of the ester bond at the sn-2 position of glycerophospholipids, releasing free fatty acids such as arachidonic acid and lysophospholipids .
    sPLA2-IIA Inhibitor
  • HY-145384
    ROC-0929

    		Phospholipase Inflammation/Immunology
    ROC-0929 (compound 13a) is a potent and selective inhibitor of secreted phospholipases A2 (sPLA2s) with an IC50 of 80 nM, specially targeting hGX. ROC-0929 inhibits the phosphorylation of ERK1/2 and p-38. Secreted phospholipases A2 (sPLA2s) are a family of disulfide-rich, Ca 2+-dependent enzymes that hydrolyze the sn-2 position of glycero-phospholipids to release a fatty acid and a lysophospholipid. ROC-0929 has the potential for researching inflammation related diseases .
    ROC-0929
  • HY-138622S1
    24:0 Lyso PC-d4

    		Isotope-Labeled Compounds Others
    24:0 Lyso PC-d44 is the deuterium labeled 24:0 Lyso PC. 24:0 Lyso PC is a lysophospholipid (LyP). 24:0 Lyso PC could be used for mRNA drug delivery .
    24:0 Lyso PC-d4
  • HY-143865
    S1PR1 agonist 2

    		LPL Receptor Inflammation/Immunology
    S1PR1 agonist 2 is a potent agonist of S1PR1. Sphingosine-1-phosphate (S1P) is a cell membrane-derived lysophospholipid signalling molecule that exerts its physiological functions mainly by stimulating some members of the G protein-coupled receptor family. S1PR1 agonist 2 has the potential for the research of autoimmune diseases (extracted from patent WO2021175225A1, compound 1) .
    S1PR1 agonist 2
  • HY-145506
    1-Stearoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) sodium

    18:0 Lyso PG sodium

    		 Liposome Metabolic Disease
    1-Stearoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (18:0 Lyso PE) sodium is a lysophospholipid containing stearic acid (18:0) at the sn-1 position. It can be used in the generation of micelles, liposomes, and other types of artificial membranes, including lipid-based drug carrier systems.
    1-Stearoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) sodium
  • HY-W713925
    Diheptanoyl Thio-PC

    		Endogenous Metabolite Metabolic Disease
    Diheptanoyl Thio-PC is a substrate for all phospholipase A2s (PLA2s) with the exception of cPLA2 and PAF-acetyl hydrolase (PAF-AH).1 Interaction of this compound with a PLA2 results in cleavage of the sn-2 fatty acid generating a free thiol on the lysophospholipid. This free thiol can be detected using chromogenic substrates such as DTNB (Ellman’s reagent) and DTP.
    Diheptanoyl Thio-PC
  • HY-143864
    S1PR1 agonist 1

    		LPL Receptor Inflammation/Immunology
    S1PR1 agonist 1 is a potent agonist of S1PR1. Sphingosine-1-phosphate (S1P) is a cell membrane-derived lysophospholipid signalling molecule that exerts its physiological functions mainly by stimulating some members of the G protein-coupled receptor family. S1PR1 agonist 1 has the potential for the research of autoimmune diseases (extracted from patent WO2021175223A1, compound 22) .
    S1PR1 agonist 1
  • HY-E70259
    18:2 (n6) Coenzyme A triammonium

    		Endogenous Metabolite Metabolic Disease
    18:2 (n6) Coenzyme A triammonium is a Coenzyme A. 18:2 (n6) Coenzyme A triammonium can be used to determine the effects of lysophospholipid acyltransferase activities in adipocyte differentiation .
    18:2 (n6) Coenzyme A triammonium
  • HY-138622S
    24:0 Lyso PC-13C6

    		Isotope-Labeled Compounds Others
    24:0 Lyso PC- 13C6 is the 13C labeled 24:0 Lyso PC. 24:0 Lyso PC is a lysophospholipid (LyP). 24:0 Lyso PC could be used for mRNA drug delivery .
    24:0 Lyso PC-13C6
  • HY-E70251
    22:6 Coenzyme A

    Docosahexaenoyl coenzyme A triammonium

    		 Endogenous Metabolite Others
    22:6 Coenzyme A (Docosahexaenoyl coenzyme A triammonium) is a coenzyme that contains 22 carbon atoms and 6 unsaturated bonds. 22:6 Coenzyme A can serve as an acyl substrate and is used in research on the effects of lysophospholipid acyltransferase activities in adipocyte differentiation .
    22:6 Coenzyme A
  • HY-107572R
    PD 128042 (Standard)

    CI 976 (Standard)

    		 Acyltransferase Reference Standards Metabolic Disease
    PD 128042 (Standard) is the analytical standard of PD 128042. This product is intended for research and analytical applications. PD 128042 (CI 976) is a potent, orally active, and selective inhibitor of ACAT (acyl coenzyme A:cholesterol acyltransferase) with an IC50s of 73 nM. PD 128042 is also a potent LPAT (lysophospholipid acyltransferase) inhibitor. PD 128042 inhibits Golgi-associated LPAT activity (IC50=15 μM). PD 128042 inhibits multiple membrane trafficking steps, including ones found in the endocytic and secretory pathway .
    PD 128042 (Standard)
  • HY-145547
    1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine

    14:0 Lyso PE; 1-Myristoyl-2-hydroxy-sn-glycero-3-PE; 1-Tetradecanoyl-sn-glycero-3-phosphoethanolamine

    		 Liposome Metabolic Disease
    1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine (14:0 Lyso PE) is a lysophospholipid with a phosphoethanolamine head and a myristoyl tail. The free amine group can conjugate with NHS active ester or coupled with carboxylic acid in the presence of a coupling agent. It also induces transient increases in intracellular calcium in PC12 cells . Serum levels of 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine are elevated in patients with malignant breast cancer compared to healthy controls .
    1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine
  • HY-181452
    1-Arachidoyl-2-hydroxy-sn-glycero-3-PA sodium

    LPA 20:0 sodium; PA(20:0/0:0) sodium; 1-Arachidoyl LPA sodium

    		 Endogenous Metabolite Endocrinology
    1-Arachidoyl-2-hydroxy-sn-glycero-3-PA sodium (LPA 20:0 sodium) (Compound LPA 20:0/lyso) is a lysophospholipid. 1-Arachidoyl-2-hydroxy-sn-glycero-3-PA sodium is detectable in urine .
    1-Arachidoyl-2-hydroxy-sn-glycero-3-PA sodium
  • HY-185237
    LysoPC(20:1(11Z))

    		Biochemical Assay Reagents Others
    LysoPC (20:1 (11Z)) is a lysophosphatidylcholine involved in lysophospholipid metabolism .
    LysoPC(20:1(11Z))
  • HY-103660S
    18:0 LYSO-PE-d35

    		Isotope-Labeled Compounds Neurological Disease
    18:0 LYSO-PE-d35 is the deuterium labeled 18:0 LYSO-PE (HY-103660). 18:0 LYSO-PE is a lysophospholipid that can induce [Ca 2+]i increase.
    18:0 LYSO-PE-d35
  • HY-113010S1
    1-Arachidoyl-sn-glycero-3-phosphocholine-d4

    		Isotope-Labeled Compounds Endogenous Metabolite Others
    1-Arachidoyl-sn-glycero-3-phosphocholine-d4 is the deuterium labeled 1-Arachidoyl-sn-glycero-3-phosphocholine. 1-Arachidoyl-sn-glycero-3-phosphocholine is a lysophospholipid (LyP).
    1-Arachidoyl-sn-glycero-3-phosphocholine-d4
  • HY-E70616
    Secreted Phospholipase A2-IIA, Human

    		Bacterial Infection
    Secreted Phospholipase A2-IIA, Human (EC 3.1.1.4), belongs to the family of antimicrobial peptides, hydrolyzes phospholipids to liberate lysophospholipids and fatty acids. Secreted Phospholipase A2-IIA, Human (EC 3.1.1.4) efficiently hydrolyzes bacterial membranes .
    Secreted Phospholipase A2-IIA, Human
  • HY-P3029C
    Phospholipase A2, Porcine

    		Phospholipase Metabolic Disease
    Phospholipase A2, Porcine (EC 3.1.1.4) hydrolyzes the β-ester bond of zwitterionic glycerophospholipids. Preferred substrates are phosphatidylcholine, phosphatidylethanolamine, and their plasmalogen analogues. Phosphatidylinositol and phosphatidylserine are also hydrolyzed. Phospholipase A2specifically recognizes the sn-2 acyl bond of phospholipids and catalytically hydrolyzes the bond releasing arachidonic acid and lysophospholipids.
    Phospholipase A2, Porcine
  • HY-P3029B
    Phospholipase A2, Streptomyces violaceoruber

    		Phospholipase Metabolic Disease
    Phospholipase A2, Streptomyces violaceoruber (EC 3.1.1.4) hydrolyzes the β-ester bond of zwitterionic glycerophospholipids. Preferred substrates are phosphatidylcholine, phosphatidylethanolamine, and their plasmalogen analogues. Phosphatidylinositol and phosphatidylserine are also hydrolyzed. Phospholipase A2specifically recognizes the sn-2 acyl bond of phospholipids and catalytically hydrolyzes the bond releasing arachidonic acid and lysophospholipids.
    Phospholipase A2, Streptomyces violaceoruber
  • HY-145547S
    1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine-d27

    14:0 Lyso PE-d27; 1-Myristoyl-2-hydroxy-sn-glycero-3-PE-d27; 1-Tetradecanoyl-sn-glycero-3-phosphoethanolamine-d27

    		 Isotope-Labeled Compounds Metabolic Disease
    1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine-d27 (14:0 Lyso PE-d27) is the deuterium labeled 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine. 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine (14:0 Lyso PE) is a lysophospholipid with a phosphoethanolamine head and a myristoyl tail. The free amine group can conjugate with NHS active ester or coupled with carboxylic acid in the presence of a coupling agent. It also induces transient increases in intracellular calcium in PC12 cells .
    1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine-d27
  • HY-W339838S
    1-Myristoyl-2-hydroxy-sn-glycero-3-PG-d27 sodium

    14:0 Lyso PG-d27 sodium

    		 Isotope-Labeled Compounds Cancer
    1-Myristoyl-2-hydroxy-sn-glycero-3-PG-d27 sodium (14:0 Lyso PG-d27) is the deuterium labeled 1-Myristoyl-2-hydroxy-sn-glycero-3-PG sodium (HY-W339838). 1-Myristoyl-2-hydroxy-sn-glycero-3-PG sodium is a lysophospholipid containing myristic acid (14:0) at the sn-1 position. It has been used in the generation of micelles, liposomes, and other types of artificial membranes, including lipid-based drug carrier systems.
    1-Myristoyl-2-hydroxy-sn-glycero-3-PG-d27 sodium
  • HY-145507S
    1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol)-d31 ammonium

    1-Palmitoyl-2-hydroxy-sn-glycero-3-PG-d31 ammonium; 16:0 Lyso PG-d31 ammonium; PG(16:0/0:0)-d31 ammonium; 1-Hexadecanoyl-sn-glycero-3-phospho-(1'racglycerol)-d31 ammonium

    		 Isotope-Labeled Compounds Metabolic Disease
    1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol)-d31 ammonium (1-Palmitoyl-2-hydroxy-sn-glycero-3-PG-d31 ammonium) is the deuterium labeled 1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) ammonium (HY-145507). 1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol) (16:0 Lyso PE) sodium is a lysophospholipid containing palmitic acid (16:0) at the sn-1 position. It can be used in the generation of micelles, liposomes, and other types of artificial membranes, including lipid-based drug carrier systems.
    1-Palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1'-rac-glycerol)-d31 ammonium
  • HY-W565665
    (S)-HPMPA

    		DNA/RNA Synthesis Others Infection
    (S)-HPMPA is an antiviral agent. (S)-HPMPA can bind to and interfere with viral DNA polymerase activity, thereby inhibiting viral DNA synthesis. (S)-HPMPA can be used for the study of DNA viruses .
    (S)-HPMPA
  • HY-W355700S
    1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine-d31

    		Isotope-Labeled Compounds Infection
    1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine-d31 is the deuterium labeled 1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine (HY-W355700). 1-oleoyl-sn-glycero-3-phosphoethanolamine (LysoPE 18:1) is a lysophosphatidylethanolamine molecule involved in phospholipid metabolism, targeting cell membrane receptors (such as G protein-coupled receptors) to regulate cell signaling pathways. 1-oleoyl-sn-glycero-3-phosphoethanolamine may activate mitogen-activated protein kinase (MAPK) signaling, promote cell migration, regulate inflammatory responses and lipid metabolism, and has both pro-inflammatory and anti-inflammatory activities. 1-oleoyl-sn-glycero-3-phosphoethanolamine is mainly used in the screening of biomarkers for metabolic diseases (such as non-alcoholic fatty liver disease and obesity), as well as the study of the mechanism of lysophospholipids in cell membrane homeostasis and signal transduction .
    1-Oleoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine-d31

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: